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a b s t r a c t
Unlike adult mammals, adult zebraﬁsh vigorously regenerate lost heart muscle in response to injury.
The epicardium, a mesothelial cell layer enveloping the myocardium, is activated to proliferate after
cardiac injury and can contribute vascular support cells or provide mitogens to regenerating muscle.
Here, we applied proteomics to identify secreted proteins that are associated with heart regeneration.
We found that Fibronectin, a main component of the extracellular matrix, is induced and deposited after
cardiac damage. In situ hybridization and transgenic reporter analyses indicated that expression of two
ﬁbronectin paralogues, fn1 and fn1b, are induced by injury in epicardial cells, while the itgb3 receptor is
induced in cardiomyocytes near the injury site. fn1, the more dynamic of these paralogs, is induced
chamber-wide within one day of injury before localizing epicardial Fn1 synthesis to the injury site.
fn1 loss-of-function mutations disrupted zebraﬁsh heart regeneration, as did induced expression of a
dominant-negative Fibronectin cassette, defects that were not attributable to direct inhibition of
cardiomyocyte proliferation. These ﬁndings reveal a new role for the epicardium in establishing an
extracellular environment that supports heart regeneration.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Fetal and neonatal mice can regenerate lost regions of heart
muscle through cardiomyocyte proliferation (Drenckhahn et al.,
2008; Porrello et al., 2011), whereas the injured adult mammalian
heart has a limited regenerative capacity. By contrast, zebraﬁsh do
not signiﬁcantly lose regenerative potential as they mature, and
can regenerate large portions of adult myocardium lost from
resection, cryoinjury, or genetic ablation (Gonzalez-Rosa et al.,
2011; Poss et al., 2002; Wang et al., 2011). In both zebraﬁsh and
mice, the epicardium, a mesothelial cell sheet that covers the
heart, is activated to induce embryonic markers after cardiac
damage (Lepilina et al., 2006). Epicardial cells have been studied
as a source of paracrine signals, a supply of perivascular compo-
nents or other cell types, and a mediator of inﬂammation during
cardiac repair or regeneration (Huang et al., 2012; Kikuchi et al.,
2011a; Smart et al., 2011; Zhou et al., 2011).
The extracellular matrix (ECM) has long been recognized as a
key inﬂuence on organ formation and repair (Martino et al., 2011).
During embryonic heart development, the ECM provides cues for
assembly, proliferation and maturation of cardiac cell types
(George et al., 1997; Ieda et al., 2009; Magnusson and Mosher,
1998; Trinh and Stainier, 2004). For instance, early cardiomyocytes
that shape the zebraﬁsh heart require the core ECM component
Fibronectin (Fn) as they migrate toward the midline, a function
that also explains observations during murine heart development
(George et al., 1997; Trinh and Stainier, 2004). Fn deposition
following cardiac damage in adult mammals has been previously
documented, where it has been associated with adverse effects
like ﬁbrosis (Knowlton et al., 1992; Rysa et al., 2005; Willems et al.,
1996; Zhong et al., 2010). Here, we ﬁnd that Fn is dynamically
produced by epicardial cells in response to cardiac injury, and that
it is essential for heart regeneration.
Materials and methods
Zebraﬁsh and cardiac injuries
Outbred Ekkwill zebraﬁsh strains (4–10 months of age) were
used for ventricular resection surgeries (Poss et al., 2002), or for
genetic cardiomyocyte ablation (Wang et al., 2011). Animal density
was maintained at approximately 4 ﬁsh per liter in all experi-
ments. To ablate cardiomyocytes, animals were treated for 16 h in
0.1 mM 4-hydroxytamoxifen (4-HT) in ﬁsh water. Transgenic tcf21:
nucEGFP and zebraﬁsh cardiac genetic ablation strains were pre-
viously described (Wang et al., 2011). Progeny from heterozygous
matings were raised at a water temperature of 22 1C to 2 months
of age, then maintained at 26 1C. fn1 homozygous mutants from
these clutches were identiﬁed by PCR screening, as described
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
0012-1606/$ - see front matter & 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ydbio.2013.08.012
n Corresponding author.
E-mail address: kenneth.poss@duke.edu (K.D. Poss).
Developmental Biology 382 (2013) 427–435
(Trinh and Stainier, 2004). Heat-shock experiments were per-
formed as described (Kikuchi et al., 2011b). Newly constructed
strains are described below. All transgenic strains were analyzed
as hemizygotes. All animal procedures were performed in accor-
dance with Duke University guidelines.
fn1:mCherry-NTR
The translational start codon of fn1 in the BAC clone CH211-
160E15 was replaced with the mCherry-NTR cassette by Red/ET
recombineering technology (Gebe Bridges) (Singh et al., 2012). The
5′ and 3′ homologous arms for recombination were a 50-base pair
(bp) fragment upstream and downstream of the start codon, and
were included in PCR primers to ﬂank the mCherry-NTR cassette.
To avoid aberrant recombination between the mCherry-NTR
cassette and endogenous loxp site in the BAC vector, we replaced
the vector-derived loxp site with an I-SceI site using the same
technology. The ﬁnal BAC was puriﬁed with Nucleobond BAC 100
kit (Clontech), and co-injected with I-SceI into one-cell-stage
zebraﬁsh embryos. The full name of this transgenic line is Tg(fn1:
mCherry-NTR)pd65.
itgb3:EGFP
The translational start codon of itgb3 in the BAC clone
DKEY-287G12 was replaced with the EGFP cassette by Red/ET
recombineering technology (GeneBridges). The procedures of the
homologous arm design, the loxp replacement strategy and BAC
preparation are the same as described above. The full name of this
transgenic line is Tg(itgb3:EGFP)pd66.
hsp70:dn-fnl1–9
A gene cassette encoding human ﬁbronectinl1–9 fragment was
PCR ampliﬁed with primers containing ClaI/ClaI (plasmid kindly
provided by Harold Erickson) (Ohashi and Erickson, 2011). PCR
products was gel-puriﬁed, digested with restriction enzymes, and
ligated into an ClaI digested vector containing the 1.5 kb zebraﬁsh
hsp70 promoter (Halloran et al., 2000). The plasmid was injected
into one-cell zebraﬁsh embryos along with I-SceI to generate
transgenic animals. The full name of this transgenic is Tg(hsp70:
fnl1–9)pd67.
Proteomics
Z-CAT zebraﬁsh were treated with EtOH vehicle or 4-HT and
ventricles were collected at 7 days post incubation (dpi), 14 dpi, and
30 dpi. Three separate pools of 3 hearts were collected for each time
point. Proteomic analysis was performed using a label-free quanti-
tative liquid chromatography–tandem mass spectrometry (LC-MS/
MS) approach after tissue solubilization (Geromanos et al., 2009).
The Duke Proteomics Core Facility received snap-frozen extracted
zebraﬁsh cardiomyocyte tissue. Each tissue sample was solubilized
using a MS-compatible surfactant/burst sonication procedure in
which samples were suspended in 50 mM ammonium bicarbonate,
pH 8 with 0.25% ALS-1 and subjected to 310 s probe sonication
bursts at 30% power. Samples were spun at 15,000 rpm for 5 min
and insoluble material was discarded. A Bradford assay (mini-
Bradford, BioRad, Inc.) of all samples was taken after protein
isolation to determine protein yield. 25 μg protein from each
sample was aliquoted and normalized to 1.0 μg/μL for reduction
(10 mM DTT), cysteine alkylation (20 mM iodoacetamide), and
trypsin digestion according to a standard protocol (http://www.
genome.duke.edu/cores/proteomics/sample-preparation/docu
ments/In-solutionDigestionProtocol_012309.doc). After digestion,
all samples were spiked with ADH1_YEAST digest (Massprep
standard, Waters Corporation) as a surrogate standard at a con-
centration of 50 fmol/μg, and acidiﬁed to a ﬁnal concentration of 2%
v/v acetonitrile and 1% triﬂuoroacetic acid. A sample “pool” to be
used for column conditioning and QC purposes was generated by
removing an equal quantity (5 μg) from each of the samples.
Quantitative LC/MS/MS was performed on 1 μg of protein
digest per sample, using a nanoAcquity UPLC system (Waters
Corp) coupled to a Synapt G2 HDMS high resolution accurate
mass tandem mass spectrometer (Waters Corp.) via a nanoelec-
trospray ionization source. Brieﬂy the sample was ﬁrst trapped on
a Symmetry C18 300 mm180 mm trapping column (5 μl/min at
99.9/0.1 v/v water/acetonitrile), after which the analytical separa-
tion was performed using a 1.7 μm Acquity BEH130 C18
75 mm250 mm column (Waters Corp.) using a 90-min gradient
of 5–40% acetonitrile with 0.1% formic acid at a ﬂow rate of 300
nL/min (nanoliters/minute) with a column temperature of 45 1C.
Quantitative data collection for each sample in singlicate and on
the sample pool (5 ) on the Synapt G2 mass spectrometer was
performed in data-independent acquisition mode (MSE) using
0.6 second alternating cycle time between low (6 V) and high
(15–40 V) collision energy (CE) in the trapping region. Additional
qualitative analyses were performed using the pooled sample in
both ion-mobility assisted data-independent acquisition (HDMSE)
mode or data-dependent acquisition (DDA) mode. Scans per-
formed at low CE measure peptide accurate mass and intensity
(abundance), while scans at elevated CE allow for qualitative
identiﬁcation of the resulting peptide fragments via database
searching. The total analysis cycle time for each sample injection
was approximately 2 h.
The QC pool containing equivalent amounts of all samples was
used to condition the UPLC column prior to the study and was run ﬁve
times throughout the study for quantitative QC and ﬁve additional
runs for supplementary qualitative identiﬁcations (for a total of 34 LC-
MS/MS analyses). Treatment groups were evenly distributed across the
run queue in a block design, and within each block the sample order
was randomized. Following the analyses, data were imported into
Rosetta Elucidator v3.3 (Rosetta Biosoftware, Inc), and all LC/LC-MS
runs were aligned based on the accurate mass and retention time of
detected ions (“features”) using PeakTeller algorithm (Elucidator). The
relative peptide abundance was calculated based on area-under-the-
curve (AUC) of aligned features across all runs. The overall dataset had
204,872 deisotoped features, and high collision energy (peptide
fragment) data was collected in 370,834 spectra for sequencing by
database searching. This MS/MS data were searched against an NCBI
RefSeq database with Danio rerio taxonomy (http://www.ncbi.nlm.nih.
gov/protein/), which also contained a reversed-sequence “decoy”
database for false positive rate determination. After individual peptide
scoring using PeptideProphet algorithm (Elucidator), the data were
annotated at a o1% peptide false discovery rate. This analysis yielded
identiﬁcations for 3897 peptides and 545 proteins across all samples,
including 325 proteins with 2 or more peptides quantiﬁed. For
quantitative processing, the data were ﬁrst curated to contain only
high quality peptides with appropriate chromatographic peak shape
and the dataset was intensity scaled to the robust mean across all
samples analyzed; the ﬁnal quantitative dataset for cardiomyocytes
was based on 3744 peptides and contains 521 proteins. Protein
expressionwithin a sample was determined by summing the intensity
of all peptides to a protein, and this sum was compared between
groups using standard statistical tools.
Histological methods
In situ hybridization (ISH) was performed on 10 mm cryosec-
tions of paraformaldehyde-ﬁxed hearts using digoxygenin-labeled
cRNA probes as described (Poss et al., 2002) with the aid of an
InSituPro robot (Intavis). Acid Fuchsin-Orange G staining was
performed as described (Poss et al., 2002). Primary antibodies
used in this study were anti-Myosin heavy chain (MHC; F59,
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mouse; Developmental Studies Hybridoma Bank), anti-Mef2 (rab-
bit; Santa Cruz), anti-PCNA (mouse; Sigma), anti-DsRed (Rabbit;
Clontech) and anti-Fibronectin (Sigma, F3648). Secondary antibo-
dies (Invitrogen) used in this study were Alexa Fluor 488 goat anti-
rabbit; Alexa 594 goat anti-rabbit, goat anti-rat and goat anti-
mouse antibodies.
Results
Fibronectin is expressed during heart regeneration
To identify proteins that are upregulated after cardiac injury and
during regeneration, we used an unbiased proteomic proﬁling
approach. We used the Zebraﬁsh Cardiac Ablation Transgenes
(Z-CAT) animals to induce cardiac damage by induced cardiomyocyte
ablation, a procedure that ablates 60% or more of all cardiomyocytes
diffusely throughout both chambers (Wang et al., 2011). These massive
injuries provoke cardiomyocyte proliferation throughout the heart,
with regeneration typically completing in 3 weeks. We performed LC-
MS analysis on cardiac tissue at 7,14, and 30 days post-injury (dpi). We
observed the largest changes in differential protein expression at
7 dpa. Over the course of regeneration, proteomic proﬁles increasingly
became more similar to the uninjured heart (Fig. 1A). Proteins
signiﬁcantly induced at 7 dpa include proteins known to be induced
during heart regeneration, such as Raldh2, Nppa, and Nppb (Gupta
et al., 2013; Kikuchi et al., 2011b; Lepilina et al., 2006). Furthermore,
we noted large changes in mitochondrial proteins such as Atp5j,
Atp5h, Mt-co2, Ndufs1, Uqcrh, and Cycsb, consistent with ultrastruc-
tural changes observed in mitochondria during heart regeneration
(Kikuchi et al., 2010). Fibronectin (Fn), a major ECM component, was
highly induced at 7 and 14 dpi, showing the 16th largest fold-change
at 7 dpi of 141 signiﬁcantly differentially expressed proteins (Fig. 1A
and B; the annotated dataset is provided in Table S1).
Fig. 1. Fibronectin expression is upregulated during heart regeneration. (A) Heat-map of the 141 differentially regulated proteins during cardiac regeneration. Red indicates
increased expression and blue indicates reduced expression. Raw data are shown in accompanying Supplemental dataset. (B) Results of quantitative proteomics show an
increase of Fn in ablated hearts at 7 days post 4-HT or vehicle incubation (dpi) and 14 dpi compared to animals treated with vehicle. Student's t-test, npo0.05.
Fig. 2. Fibronectin is dynamically expressed during heart regeneration. (A and B) Fibronectin expression by immunostaining in uninjured (A) and 7 dpa (B) ventricles,
localizing to the injury site. MHC, Myosin heavy chain. (C–J) In situ hybridization for fn1 and fn1b in uninjured, 1, 7 and 30 dpa ventricles. In each section, violet indicates a
positive signal. Dashed line indicates approximate resection plane. Scale bars: 50 mm.
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Fibronectin paralogs are dynamically expressed during heart
regeneration
To conﬁrm this induction, we assessed ventricles injured locally
by partial ventricular resection, using an antibody that recognizes
gene products of the two zebraﬁsh Fn paralogs, Fn1 and Fn1b, (Sun
et al., 2005), and identiﬁed strong Fn immunoreactivity in injury
sites at 7 days post-amputation (7 dpa) (Fig. 2A and B).
To examine the expression patterns of individual Fn paralogs
during heart regeneration, we performed in situ hybridization
using riboprobes that are speciﬁc for either fn1 or fn1b. fn1 was
undetectable in the uninjured heart (Fig. 2C), strongly induced on
the periphery of the ventricular wall both near and away from the
injury site by 1 dpa (Fig. 2D), and localized to the injured
ventricular apex by 7 and 14 dpa (Fig. 2E and data not shown).
By 30 dpa, a time when the myocardial wall has typically been
replaced, we detected little or no fn1 (Fig. 2F). The fn1b paralog
was expressed in cells all along the periphery of uninjured
ventricles (Fig. 2G), was induced strongly at 1, 7, and 14 dpa in a
similar manner as fn1 (Fig. 2H and I, and data not shown), and
retained expression in the ventricle at 30 dpa (Fig. 2J). These
results revealed dynamic, organ-wide induction by both fn para-
logs, possibly in the same cell type(s) within the ventricular wall
and injured apex. Notably, the fn1 paralog displayed an injury
proﬁle that suggested a role speciﬁc to regeneration.
fn1 Is induced predominantly in epicardial cells during heart
regeneration
The immunoﬂuoresence and in situ hybridization results sug-
gested expression of one or both fn paralogs in epicardial cells, but
were unable to deﬁnitively specify the source of Fn. Therefore, we
generated a BAC transgenic reporter strain that would mark cells
activating fn1 gene expression Tg(fn1:mCherry-NTR)pd65 (referred to
hereafter as fn1:mCherry-NTR). This cassette includes a bacterial
nitroreductase coding sequence that can in practice be used for
ablation of expressing cells (Curado et al., 2007). Fluorescent protein
Fig. 3. Fibronectin is synthesized predominantly by epicardial cells during heart regeneration. (A) Visualization of fn1:mCherry-NTR-expressing cells at 2 dpf. White arrows
show fn1:mCherry-NTRþ cells. (B–M) Visualization of fn1:mCherry-NTRþ cells (red) and epicardial cells (tcf21:nucEGFPþ; green) in uninjured, 1 and 7 dpa ventricles. Boxed
area indicates an enlarged view. Arrows indicate double-positive cells. Dashed line indicates approximate resection plane. Scale bars: 50 mm.
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expression in fn1:mCherry-NTR embryos largely recapitulated endo-
genous fn1 expression (Fig. 3A) (Rauch et al., 2003). In adults, fn1:
mCherry-NTR expression was undetectable in the uninjured heart
(Fig. 3B, C and D), but appeared to reproduce endogenous expression
of fn1 in the injured ventricular apex by 7 dpa (Fig. 3H and J, and
Fig. 2C and E). In double transgenic animals, fn1:mCherry-NTR
ﬂuorescence co-localized with that of the epicardial marker tcf21:
nucEGFP, demonstrating epicardial expression at 7 dpa during regen-
eration (Fig. 3K, L and M). We found that fn1:mCherry-NTR ﬂuores-
cence colocalized with tcf21:nucEGFP at 1 dpa in areas lateral to the
injury site (Fig. 3E, F and G). Although we had observed some fn1-
expressing cells in the 1 dpa injury site by in situ hybridization
(Fig. 2D), we typically did not see cells in the wound positive for
fn1:mCherry-NTR and/or tcf21:nucEGFP ﬂuorescence. Therefore, we
suspect that the reporter may have a lag time for strong ﬂuorescence
versus mRNA induction, or is simply not as sensitive. However, we
cannot rule out that there is another cell type(s) that expresses fn1
and/or fn1b at 1 dpa. Additionally, we did not observe colocalization
with cardiomyocyte-speciﬁc or endothelial/endocardial cell markers.
These results revealed that Fn1 is induced and secreted predominantly
by epicardial cells in response to cardiac injury, and suggested a role
for Fn1 in facilitating heart regeneration.
The Fibronectin receptor itgb3 is induced in cardiomyocytes near the
injury site
Fn interacts with various integrin partners that mediate signal
transduction (Labat-Robert, 2012). We performed in situ hybridization
Fig. 4. The Fibronectin partner integrin β3 is expressed during heart regeneration. (A and B) itgb3 expression by in situ hybridization in uninjured (A) and 7 dpa (B) ventricles.
(C) Visualization of embryonic itgb3:EGFP-expressing cells (green). Boxed areas indicates a higher magniﬁcation view of the heart (area 1), pectoral ﬁn (area 2) and posterior ﬁn fold
(area 3). (D and E) Visualization of itgb3:EGFPþ cells (green) in uninjured (D) and 7 dpa (E) ventricles. Insets: high magniﬁcation of the boxed area. Blue arrows indicate EGFP-
positive cells. Yellow arrows indicate EGFP and MHC double-positive cells, indicative of cardiomyocytes. Dashed line indicates approximate resection plane. Scale bars: 50 mm.
J. Wang et al. / Developmental Biology 382 (2013) 427–435 431
to screen for expression of several integrin genes, and identiﬁed
expression of integrin b3 (itgb3) and αV (itgαV) during heart regenera-
tion (Fig. 4A and B, and data not shown). These integrin receptors,
which are also present during heart development (Ablooglu et al.,
2007), were upregulated in the injured ventricular apex at 7 dpa, with
itgb3 showing particularly strong expression (Fig. 4A and B). To
determine the cell type that expresses itgb3 during heart regeneration,
we generated a BAC transgenic reporter strain using itgb3 regulatory
sequences, Tg(itgb3:EGFP)pd66 (hereafter referred to as itgb3:EGFP).
EGFP ﬂuorescence in itgb3:EGFP embryos recapitulated endogenous
itgb3 expression domains (Ablooglu et al., 2007) (Fig. 4C). In the
uninjured heart, itgb3:EGFP ﬂuoresence was occasionally present in
blood cells (Fig. 4D). However, by 7 dpa, we observed expression in
many cardiomyocytes near and within the injury site (Fig. 4E). These
results indicated that cardiomyocytes in the area of trauma induce
expression of integrins that can transduce signals from the Fn
deposited by epicardial cells.
Fn is required for heart regeneration
Fn has been implicated in multiple cellular processes relevant
to tissue repair and regeneration, including cell proliferation, cell
migration, cellular dedifferentiation, and ﬁbrosis (Frangogiannis,
2008; Singh et al., 2010; Singh and Schwarzbauer, 2012; Willems
et al., 1996). To examine whether Fn is required for heart
regeneration, we generated a transgenic strain that enables
Fig. 5. Fibronectin is required for heart regeneration. (A and B) Wild-type embryos (A), or embryos from a cross between hemizygous hsp70:fnI1–9 and wild-type parents
(B), were heat-shocked at 6 h post-fertilization (hpf) at 38 1C for 40 min and imaged at 24 hpf. Wild-type embryos appeared largely normal after this treatment (92.4%
normal, 7.6% general dysmorphology, n¼303). By contrast 61.4% of embryos from the transgenic cross developed a markedly shortened body axis (n¼264). (C and D) In situ
hybridization for fnI1–9 in wild-type (C) and hsp70:fnI1–9 clutchmate (D) ventricles at 1 day post heat-shock (dphs). (E–H) MHC (Myosin heavy chain; green) staining and
collagen staining of hsp70:fnI1–9 (E and G) and wild type clutchmate (F and H) ventricles at 30 dpa. Three of 10 ventricles of heat-shocked clutchmates showed obvious areas
of missing myocardium, compared to 9 of 10 ventricles in hsp70:fnI1–9 ﬁsh. Fisher Irwin exact test, *po0.05. Black arrows indicate ﬁbrosis. Dashed line indicates
approximate resection plane. Scale bars: 50 mm.
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heat-inducible expression of a dominant-negative human ﬁbro-
nectin fragment Tg(hsp70:fnI1–9)pd67 (Halloran et al., 2000; Ohashi
and Erickson, 2011). Following a single heat-shock, transgenic
embryos displayed a shortened body axis similar to the reported
phenotype upon co-injection of morpholinos against both fn
paralogs (Julich et al., 2005) (Fig. 5A and B). Adult transgenic ﬁsh
and wild-type clutchmates were given partial resection injuries
followed by a daily heat-shock from 3 to 30 dpa. This treatment
had no detectable effect on the distribution of Fn protein in wild-
type and transgenic clutchmates (Fig. S1). Ventricles were col-
lected and analyzed at 30 dpa. This treatment induced fnI1–9
strongly in cardiomyocytes throughout the ventricle (Fig. 5C and
D) and caused an increased incidence of regenerative failure
(Fig. 5E and F) and ﬁbrosis (Fig. 5G and H), presumably by
disupting Fn function in the area of regeneration. While we did
not notice gross deleterious consequences of expressing truncated
Fn on other aspects of cardiac or animal physiology, such effects
are possible in this type of experiment.
As the fn1 paralog is localized to the injured ventricular apex by
7 and 14 dpa (Fig. 2E), we then analyzed zebraﬁsh homozygous for
a null mutation in fn1. While fn1 mutants have defects in cardiac
development at temperatures typically used to raise zebraﬁsh,
some mutant animals are capable of surviving to adulthood when
raised at 22 1C (Trinh and Stainier, 2004). The temperature-sensitive
nature of the mutation is likely due to functional compensation by
Fn1b, combined with the fact that embryogenesis happens more
slowly at lower temperatures. To examine the requirement for Fn1
function during heart regeneration, we raised animals from fn1/þ
crosses at 22 1C until 2 months of age, after which we maintained
animals at 26 1C. We injured adult fn1/fn1 and wild-type or fn1/þ
clutchmates and assessed regeneration after 30 days. In these
experiments, similar to hsp70:fnI1–9 animals, fn1/fn1 ﬁsh were less
frequently able to regenerate a contiguous wall of new muscle
(Fig. 6A and B), resulting in ﬁbrosis (Fig. 6C and D). Quantiﬁcation of
the regenerated muscle at 30 dpa indicated fn1/fn1 ﬁsh showed
signiﬁcantly less muscle in the injury site than fn1/þ clutchmates
(Fig. S2A, B and C). Based on these genetic data, we conclude that Fn
is required for normal heart regeneration.
Fibronectin loss-of-function does not directly inhibit cardiomyocyte
proliferation
The source of new heart muscle in zebraﬁsh is pre-existing
cardiomyocytes, which are stimulated by injury to proliferate and
replace lost myocardium (Jopling et al., 2010; Kikuchi et al., 2010).
To determine if heart regeneration defects caused by Fn loss-of-
function result directly from inhibited cardiomyocyte proliferation,
we quantiﬁed the percentage of proliferating myocytes in our
transgenic and mutant strains. Adult transgenic ﬁsh and wild-type
clutchmates were given partial resection injuries followed by a
daily heat-shock from 3 to 7 dpa. Ventricles were collected and
analyzed at 7 dpa. At 7 dpa, cardiomyocyte proliferation indices
were comparable between fn1 mutant, fnI1–9-expressing, and
their respective control groups (Fig. 7A and F). These results
indicate that Fn deposited in the ECM after cardiac injury does
not facilitate muscle regeneration via direct regulation of cardio-
myocyte proliferation. We then examined the distribution of
cardiomyocytes adjacent to the injured area at 30 dpa in fn1/fn1
mutant and fn1/þ clutchmates. Quantiﬁcation of cardiomyocyte
nuclear density in areas ﬂanking the injury at 30 dpa indicated a
higher cellular density in fn1/fn1 mutant animals (Fig. S2D, E, and
F). These data suggest that Fn is required for cardiomyocyte
mobilization and integration into the injury site.
Discussion
Here, we have used a series of expression analyses to identify a
key response by the epicardium that enriches Fn in the injury site
after cardiac damage in zebraﬁsh. Together, our genetic, trans-
genic, and expression data point to a model for epicardial regula-
tion of the ECM. Cardiac damage boosts Fn1 and Fn1b levels
predominantly in epicardial cells throughout the ventricle, a
response that localizes to the wound site with similar dynamics
as other epicardial markers induced by injury (Kikuchi et al.,
2011b; Lepilina et al., 2006). As the injury site accumulates
Fn, itgb3 is upregulated in cardiomyocytes where it can facilitate
Fig. 6. Fibronectin1 mutants show defective heart regeneration. (A–D) Myosin heavy chain (MHC; green) staining (A and B) and collagen staining (C and D) of wild-type and
homozygous fn1 mutant ventricles at 30 dpa. One of 10 wild-type and 7 of 12 fn1 mutant ventricles showed obvious areas of depleted myocardium. Dashed line indicates
approximate resection plane. Fisher Irwin exact test, *po0.05. Scale bars: 50 mm.
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regenerative responses. Our evidence for a pro-regenerative ECM
thus suggests a new interaction between the epicardium and the
myocardium that is important for regeneration, and that may be
relevant to ECM changes during other examples of tissue regen-
eration (Bentzinger et al., 2013; Calve et al., 2010; Martino et al.,
2011; Tonge et al., 2012). These ﬁndings add to a growing body of
literature identifying diverse roles for the epicardium in promoting
heart regeneration.
Fn is well-studied for its inﬂuences on cell adhesion and migra-
tion, and loss of Fn function in zebraﬁsh, avian or mouse embryos
leads to complete or partial failure of fusion by the cardiac primordia
(George et al., 1997; Linask and Lash, 1988; Trinh and Stainier, 2004).
Although Fn secretion from embryonic cardiac ﬁbroblasts can
promote the proliferation of cultured mammalian cardiomyocytes
(Ieda et al., 2009), our data do not implicate Fn signaling directly in
cardiomyocyte proliferation during heart regeneration. As a recent
study suggested that migration of cardiomyocytes is important for
zebraﬁsh heart regeneration (Itou et al., 2012), our ﬁndings raise the
possibility that Fn/Itgb3 interactions are involved in such an event.
Other possible functions of Fn in a regenerative ECM include
regulation of inﬂammatory cell function; epicardial cell behaviors
like migration, proliferation, and differentiation; and vascularization
of the regenerate.
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